Basic Pharma | Basic Pharma Manufacturing

Manufacturing, testing and distribution of investigational medicinal products (IMPs) is strongly regulated by the relevant authorities to assure high quality when administered to patients in clinical trials. Full transparency and traceability, from the origin of the starting materials to dosing and the ultimate destruction of the study medication, all in compliance with Good Manufacturing practices (GMP), is mandatory. Maintaining a GMP-certified status for clean rooms requires continuous investment in equipment, facilities and well-trained people.